Factors Associated with Performance of Activities and Participation of Brazilian Children and Adolescents with Cerebral Palsy: A Cross-Sectional Study.

The aim of this study was to investigate factors related to performance in daily activities, mobility, social/cognitive skills, and responsibility of Brazilian children/adolescents with cerebral palsy (CP). Multivariate binary logistic regression analyses were performed. A total of 190 children/adolescents participated.

Functioning profile and related impairments of children and adolescents with cerebral palsy - PartiCipa Brazil preliminary results.

Background: Limited information is available about functioning and related impairments of children and adolescents with Cerebral Palsy (CP) in low- and middle-income countries (LMIC) like Brazil. The aim of this study is to describe the characteristics, functioning, and impairments of Brazilian children and adolescents with CP.

Methods: Cross-sectional preliminary study as part of the PartiCipa Brazil multicentered cohort study.

Hybrid developmental follow-up for preterm infants in Brazil: A feasibility study.

Introduction: The low attendance of families in child developmental follow-up programs for at-risk preterm children is a challenge in Brazil.

Objective: This study evaluates the feasibility of implementing a developmental follow-up program for Brazilian preterm infants in a hybrid format.

Methods: This is an observational, prospective cohort study, involving preterm infants.

Antimicrobial Use in Pig Farms in the Midwestern Region of Minas Gerais, Brazil.

The use of antimicrobials in swine production is an issue that concerns the whole world due to their impact on animal and public health. This study aimed to verify the antimicrobial use in 29 commercial full-cycle farms in the midwestern region of the state of Minas Gerais, since this region is a hub of intensive pig farming in Brazil, as well as the possible correlations between the use of antimicrobials, biosecurity, and productivity. A total of 28 different drugs used for preventive purposes were described.

The Best Supportive Care in Stage III Non-Small-Cell Lung Cancer.

Lung cancer is a major cause of cancer deaths worldwide. Non-small-cell lung cancer (NSCLC) represents most lung cancer cases, and approximately one-third of patients present with stage III disease at diagnosis. As multiple treatment plans can be adopted for these patients depending on tumor size and nodal staging, stage III NSCLC management is challenging.